PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:39 AM ET

Sponsor Check › Person

MG
No photo found yet (own website and image search run after this page is viewed)

Michael Gilman

Named as an officer, director or promoter on SEC Form D filings · MA · Nov 30, 2010 → Apr 18, 2019

7deals (issuers)
$170.7Mreported sold
283investors
11Form D filings
2010–2019years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:22 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Michael Gilman is listed as an executive officer and director on 11 SEC Form D filings by 7 issuers between Nov 2010 and Apr 2019. Largest by amount reported sold: Scholar Rock Holding Corp (Cambridge, MA — biotechnology — 2018; $47M reported sold to 19 investors), X4 Pharmaceuticals, Inc. (Cambridge, MA — pharmaceuticals — 2015–2018; $37.5M reported sold to 220 investors), Scholar Rock LLC (Cambridge, MA — biotechnology — 2016; $36.3M reported sold to 11 investors), Obsidian Therapeutics, Inc. (Cambridge, MA — biotechnology — 2017; $32.4M reported sold to 8 investors), Arrakis Therapeutics, Inc. (Waltham, MA — biotechnology — 2017–2019; $15M reported sold to 15 investors) and 2 more (all listed below).

What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer and director, over about 9 years. Across those companies the filings report $170.7M sold in total.

Listed alongside Alan E. Walts (5 shared filings), Paula Ragan (4 shared filings), Isaac Blech (3 shared filings), Amir Nashat (2 shared filings), Colleen Cuffaro (2 shared filings) and 42 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.

The issuers belong to 2 sponsor groups: Scholar Rock (2 issuers, $83.3M reported sold, 2016–2018) and X4 Pharmaceuticals (2 issuers, $120M reported sold, 2010–2025).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 21 bankruptcy cases matching the name listed in Key records below.

What this means 22 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 11 public filings for Michael Gilman and found 10 differences: Michael Gilman appears on 2 deals that stopped filing before reaching their target; Form D filed 17 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Michael Gilman has not run yet — it is joining a line of 25,140 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 dismissed

SCHENCK v. MICHAEL GILMAN dismissed
District Court, D. New Jersey · No. 3:94-cv-02327 · Filed May 17, 1994 · Closed Aug 16, 1994 · Nature of suit: 190 Other contract actions
Role of MICHAEL GILMAN: Defendant · Outcome: Terminated 1994-08-16 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in NJ (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:22 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Michael Gilman..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

21 cases: 21 closed (disposition not in docket feed)

Michael D. Gilman closed
United States Bankruptcy Court, D. Massachusetts · No. 24-40258 · Filed Mar 18, 2024 · Closed Jul 1, 2024
Role of Michael D. Gilman: Debtor · Outcome: Case closed 2024-07-01 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in the person's filing state (MA)
Michael K. Gilman and Lisa M. Gilman closed
United States Bankruptcy Court, W.D. Michigan · No. 16-06148 · Filed Dec 8, 2016 · Closed May 22, 2019
Role of Michael K. Gilman and Lisa M. Gilman: Debtor · Outcome: Case closed 2019-05-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in MI (not a filing state)
Michael Gilman closed
United States Bankruptcy Court, E.D. Michigan · No. 12-59410 · Filed Aug 23, 2012 · Closed Jul 31, 2013
Role of Michael Gilman: Debtor · Outcome: Case closed 2013-07-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in MI (not a filing state)
Michael T. Gilman closed
United States Bankruptcy Court, D. New Jersey · No. 12-27431 · Filed Jul 12, 2012 · Closed Oct 31, 2017
Role of Michael T. Gilman: Debtor · Outcome: Case closed 2017-10-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in NJ (not a filing state)
Michael P. Gilman closed
United States Bankruptcy Court, D. Colorado · No. 12-14636 · Filed Mar 13, 2012 · Closed Aug 8, 2012
Role of Michael P. Gilman: Debtor · Outcome: Case closed 2012-08-08 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in CO (not a filing state)
Michael J. Gilman and Aubrea M. Gilman closed
United States Bankruptcy Court, E.D. Washington · No. 11-00544 · Filed Feb 8, 2011 · Closed May 11, 2011
Role of Michael J. Gilman and Aubrea M. Gilman: Debtor · Outcome: Case closed 2011-05-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in WA (not a filing state)
Michael H Gilman and Melinda W. Gilman closed
United States Bankruptcy Court, D. Maine · No. 10-21692 · Filed Oct 7, 2010 · Closed Jan 18, 2011
Role of Michael H Gilman and Melinda W. Gilman: Debtor · Outcome: Case closed 2011-01-18 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in ME (not a filing state)
Michael T. Gilman closed
United States Bankruptcy Court, D. Maine · No. 09-11356 · Filed Oct 2, 2009 · Closed Jan 19, 2010
Role of Michael T. Gilman: Debtor · Outcome: Case closed 2010-01-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in ME (not a filing state)
Michael B. Gilman and April N. Gilman closed
United States Bankruptcy Court, D. Maryland · No. 07-10617 · Filed Jan 20, 2007 · Closed Sep 24, 2008
Role of Michael B. Gilman and April N. Gilman: Debtor · Outcome: Case closed 2008-09-24 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in MD (not a filing state)
Michael A. Gilman and AnnMarie Gilman closed
United States Bankruptcy Court, W.D. Texas · No. 05-61940 · Filed Aug 12, 2005 · Closed Dec 6, 2005
Role of Michael A. Gilman and AnnMarie Gilman: Debtor · Outcome: Case closed 2005-12-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in TX (not a filing state)
Michael Gilman closed
United States Bankruptcy Court, E.D. Arkansas · No. 1:05-bk-12701 · Filed Mar 3, 2005 · Closed Apr 12, 2006
Role of Michael Gilman: Debtor · Outcome: Case closed 2006-04-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in AR (not a filing state)
Michael W. Gilman closed
United States Bankruptcy Court, D. Maine · No. 03-10919 · Filed May 14, 2003 · Closed Aug 29, 2003
Role of Michael W. Gilman: Debtor · Outcome: Case closed 2003-08-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in ME (not a filing state)
Michael C. Gilman and Tanya M. Gilman closed
United States Bankruptcy Court, D. Colorado · No. 02-19615 · Filed Jun 24, 2002 · Closed Oct 31, 2002
Role of Michael C. Gilman and Tanya M. Gilman: Debtor · Outcome: Case closed 2002-10-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in CO (not a filing state)
MICHAEL J GILMAN and AUBREA GILMAN closed
United States Bankruptcy Court, E.D. Washington · No. 02-02571 · Filed Mar 28, 2002 · Closed Jan 25, 2007
Role of MICHAEL J GILMAN and AUBREA GILMAN: Debtor · Outcome: Case closed 2007-01-25 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in WA (not a filing state)
Michael E. Gilman and Christine A. Gilman closed
United States Bankruptcy Court, M.D. Florida · No. 6:01-bk-12721 · Filed Dec 26, 2001 · Closed May 30, 2002
Role of Michael E. Gilman and Christine A. Gilman: Debtor · Outcome: Case closed 2002-05-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in FL (not a filing state)
Michael J. Gilman closed
United States Bankruptcy Court, N.D. Ohio · No. 01-10076 · Filed Jan 4, 2001 · Closed May 3, 2001
Role of Michael J. Gilman: Debtor · Outcome: Case closed 2001-05-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in OH (not a filing state)
Michael A. Gilman and Vanessa I. Gilman closed
United States Bankruptcy Court, M.D. Florida · No. 8:98-bk-13927 · Filed Aug 10, 1998 · Closed Dec 16, 1998
Role of Michael A. Gilman and Vanessa I. Gilman: Debtor · Outcome: Case closed 1998-12-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in FL (not a filing state)
Michael W. Gilman closed
United States Bankruptcy Court, N.D. California · No. 98-41605 · Filed Feb 25, 1998 · Closed Jun 5, 1998
Role of Michael W. Gilman: Debtor · Outcome: Case closed 1998-06-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in CA (not a filing state)
Michael J Gilman closed
United States Bankruptcy Court, C.D. California · No. 6:97-bk-26932 · Filed Sep 26, 1997 · Closed Jan 20, 1998
Role of Michael J Gilman: Debtor · Outcome: Case closed 1998-01-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in CA (not a filing state)
Michael K. Gilman and Tricia E. Gilman closed
United States Bankruptcy Court, C.D. California · No. 8:94-bk-22560 · Filed Dec 14, 1994 · Closed May 23, 1995
Role of Michael K. Gilman and Tricia E. Gilman: Debtor · Outcome: Case closed 1995-05-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in CA (not a filing state)
Michael J. Gilman closed
United States Bankruptcy Court, N.D. New York · No. 93-60306 · Filed Feb 3, 1993 · Closed Jun 15, 1993
Role of Michael J. Gilman: Debtor · Outcome: Case closed 1993-06-15 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 35 federal dockets); 4 people with this name in Form D filings; court in NY (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:22 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

10 differences found between the filings for Michael Gilman (compared 11 filings on Oct 24, 2026)

Note · Jan 25, 2011 – Apr 18, 2019

Michael Gilman appears on 2 deals that stopped filing before reaching their target

Arrakis Therapeutics, Inc. (last filing Apr 18, 2019; $14,999,992 sold of $74,999,986); Stromedix Inc (last filing Jan 25, 2011; $2,000,000 sold of $15,500,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Arrakis Therapeutics, Inc. — PartnerFacts page ↗Stromedix Inc — PartnerFacts page ↗
Sources
Note · Dec 22, 2017 – Jan 8, 2018

Form D filed 17 days after the first sale — Scholar Rock Holding Corp

The filing says the first sale was Dec 22, 2017. The Form D was filed Jan 8, 2018 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jan 8, 2018 ↗Scholar Rock Holding Corp — PartnerFacts page ↗
Sources
Note · Dec 17, 2015 – Jan 4, 2016

Form D filed 18 days after the first sale — Scholar Rock LLC

The filing says the first sale was Dec 17, 2015. The Form D was filed Jan 4, 2016 — 18 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 3 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jan 4, 2016 ↗Scholar Rock LLC — PartnerFacts page ↗
Sources
Note · Nov 15, 2010 – Apr 18, 2019

9 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Arrakis Therapeutics, Inc. (latest filing Apr 18, 2019) · No amendment in the last 12 months on an offering that may still be open — Scholar Rock Holding Corp (latest filing Jan 8, 2018) · No amendment in the last 12 months on an offering that may still be open — Obsidian Therapeutics, Inc. (latest filing Dec 8, 2017) · No amendment in the last 12 months on an offering that may still be open — Arrakis Therapeutics, Inc. (latest filing Mar 2, 2017) · No amendment in the last 12 months on an offering that may still be open — Scholar Rock LLC (latest filing Jan 4, 2016) · and 4 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Apr 18, 2019 ↗Arrakis Therapeutics, Inc. — PartnerFacts page ↗Form D · Jan 8, 2018 ↗Scholar Rock Holding Corp — PartnerFacts page ↗
Sources
Note · Nov 15, 2017 – Sep 21, 2018

Offering amount changed between filings — X4 Pharmaceuticals, Inc.

The Nov 15, 2017 filing says $30,000,000 offered; the Sep 21, 2018 Form D/A says $34,999,150.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Nov 15, 2017 ↗Form D/A (later) · Sep 21, 2018 ↗X4 Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jan 20, 2022 – Nov 27, 2024

Same name, different state: "Michael Gilman" (TX) is a separate record

This page covers filings where the address state is MA. A separate record, "Michael Gilman" with address state TX, is listed on 3 filings — most recently by KP Prism REIT, LLC (Nov 27, 2024). The two records do not overlap in time: this page runs Nov 30, 2010 to Apr 18, 2019; the other runs Jan 20, 2022 to Nov 27, 2024.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Michael Gilman (TX) — PartnerFacts page ↗Form D · Nov 27, 2024 ↗KP Prism REIT, LLC — PartnerFacts page ↗Michael Gilman (MA) — this page ↗
Sources
Note · Aug 13, 2021 – Oct 19, 2022

Same name, different state: "Michael Gilman" (NY) is a separate record

This page covers filings where the address state is MA. A separate record, "Michael Gilman" with address state NY, is listed on 3 filings — most recently by Cross Mountain Capital Multifamily Alpha Fund LLC (Oct 19, 2022). The two records do not overlap in time: this page runs Nov 30, 2010 to Apr 18, 2019; the other runs Aug 13, 2021 to Oct 19, 2022.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Michael Gilman (NY) — PartnerFacts page ↗Form D · Oct 19, 2022 ↗Cross Mountain Capital Multifamily Alpha Fund LLC — PartnerFacts page ↗Michael Gilman (MA) — this page ↗
Sources
Note · Feb 11, 2021 – Apr 7, 2022

Same name, different state: "Michael Gilman" (CO) is a separate record

This page covers filings where the address state is MA. A separate record, "Michael Gilman" with address state CO, is listed on 2 filings — most recently by 6980 Stuart St, LLC (Apr 7, 2022). The two records do not overlap in time: this page runs Nov 30, 2010 to Apr 18, 2019; the other runs Feb 11, 2021 to Apr 7, 2022.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Michael Gilman (CO) — PartnerFacts page ↗Form D · Apr 7, 2022 ↗6980 Stuart St, LLC — PartnerFacts page ↗Michael Gilman (MA) — this page ↗
Sources
Note · Mar 2, 2017 – Apr 18, 2019

Address moved from Cambridge, MA to Waltham, MA — Arrakis Therapeutics, Inc.

The people listed on the Mar 2, 2017 filing give Cambridge, MA; on the Apr 18, 2019 filing they give Waltham, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Mar 2, 2017 ↗Form D · Apr 18, 2019 ↗Arrakis Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jan 30, 2015 – Aug 28, 2015

Address moved from Belmont, MA to Cambridge, MA — X4 Pharmaceuticals, Inc.

The people listed on the Jan 30, 2015 filing give Belmont, MA; on the Aug 28, 2015 filing they give Cambridge, MA. The address now on file (955 Massachusetts Avenue, Cambridge, MA) is a registered-agent or shared-office address used by 6 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Jan 30, 2015 ↗Form D · Aug 28, 2015 ↗X4 Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 10 offerings report sales commissions totalling $5,373,224; 0 report finder's fees; 1 reports proceeds to related persons totalling $150,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 18, 2019 D
Arrakis Therapeutics, Inc.
File 021-337635
$0$0$0None listed on this filingEDGAR ↗
Sep 21, 2018 D/A
X4 Pharmaceuticals, Inc.
File 021-298854
$2,373,224 (est.)$0$0Maxim Group, LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Jan 8, 2018 D
Scholar Rock Holding Corp
File 021-302683
$0$0$0None listed on this filingEDGAR ↗
Dec 8, 2017 D
Obsidian Therapeutics, Inc.
File 021-300326
$0$0$0None listed on this filingEDGAR ↗
Mar 2, 2017 D
Arrakis Therapeutics, Inc.
File 021-281666
$0$0$0None listed on this filingEDGAR ↗
Jan 4, 2016 D
Scholar Rock LLC
File 021-254433
$0$0$0None listed on this filingEDGAR ↗
Aug 28, 2015 D
X4 Pharmaceuticals, Inc.
File 021-246624
$3,000,000 (est.)$0$150,000 (est.)Maxim Group, LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Jan 30, 2015 D
X4 Pharmaceuticals, Inc.
File 021-233180
$0$0$0None listed on this filingEDGAR ↗
Jan 25, 2011 D
Stromedix Inc
File 021-154307
$0$0$0None listed on this filingEDGAR ↗
Nov 30, 2010 D
GENE NETWORK SCIENCES, INC.
File 021-151160
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 7

Every issuer that named Michael Gilman on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

AT
Biotechnology

Arrakis Therapeutics, Inc.

Waltham, MA · Mar 2, 2017 → Apr 18, 2019 · 2 filings
  • Apr 18, 2019 · D · $14,999,992 sold of $74,999,986 · 15 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 2, 2017 · D · $13,238,466 sold of $41,238,467 · 8 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $15M from 15 investors (20% of the $75M target) as of the latest filing. Michael is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

XP
Pharmaceuticals · group: X4 Pharmaceuticals

X4 Pharmaceuticals, Inc.

Cambridge, MA · Jan 30, 2015 → Sep 21, 2018 · 4 filings
  • Sep 21, 2018 · D/A · $34,999,150 sold of $34,999,150 · 214 investors · min. $50,000 · role: Director EDGAR ↗
  • Nov 15, 2017 · D · $25,838,812 sold of $30,000,000 · 213 investors · min. $50,000 · role: Director EDGAR ↗
  • Aug 28, 2015 · D · $37,499,999 sold of $37,500,000 · 220 investors · min. $24,579 · role: Director EDGAR ↗
  • Jan 30, 2015 · D · $735,000 sold of $1,200,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $37.5M from 220 investors (100% of the $35M target) as of the latest filing. Michael is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SR
Biotechnology · group: Scholar Rock

Scholar Rock Holding Corp

Cambridge, MA · Jan 8, 2018
  • Jan 8, 2018 · D · $46,999,998 sold of $47,000,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $47M from 19 investors (100% of the $47M target) as of the latest filing. Michael is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

OT
Biotechnology

Obsidian Therapeutics, Inc.

Cambridge, MA · Dec 8, 2017
  • Dec 8, 2017 · D · $32,436,323 sold of $49,936,323 · 8 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $32.4M from 8 investors (65% of the $49.9M target) as of the latest filing. Michael is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SR
Biotechnology · group: Scholar Rock

Scholar Rock LLC

Cambridge, MA · Jan 4, 2016
  • Jan 4, 2016 · D · $36,296,355 sold of $40,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $36.3M from 11 investors (91% of the $40M target) as of the latest filing. Michael is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Pharmaceuticals

Stromedix Inc

Cambridge, MA · Jan 25, 2011
  • Jan 25, 2011 · D · $2,000,000 sold of $15,500,000 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $2M from 9 investors (13% of the $15.5M target) as of the latest filing. Michael is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

GN
Other Technology

GENE NETWORK SCIENCES, INC.

Cambridge, MA · Nov 30, 2010
  • Nov 30, 2010 · D · $450,000 sold of Indefinite · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $450K from 1 investor as of the latest filing. Michael is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Michael Gilman — NY, 3 issuers, Aug 13, 2021 → Oct 19, 2022 · no shared issuer
  • Michael Gilman — CO, 2 issuers, Feb 11, 2021 → Apr 7, 2022 · no shared issuer
  • Michael Gilman — TX, 2 issuers, Jan 20, 2022 → Nov 27, 2024 · no shared issuer

People around Michael 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Alan E. Walts

Director, Executive Officer · 5 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

PR
No photo found yet (own website and image search run after this page is viewed)
Person

Paula Ragan

Executive Officer, Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

IB
No photo found yet (own website and image search run after this page is viewed)
Person

Isaac Blech

Director · 3 shared filings (1 issuer) · also on 19 other issuers

Isaac Blech is on 20 issuers in total — a repeat sponsor. Their page lists every one.

DN
No photo found yet (own website and image search run after this page is viewed)
Person

David Neafus

Executive Officer · 2 shared filings (2 issuers) · also on 9 other issuers

David Neafus is on 11 issuers in total — a repeat sponsor. Their page lists every one.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Amir Nashat

Director · 2 shared filings (2 issuers) · also on 27 other issuers

Amir Nashat is on 29 issuers in total — a repeat sponsor. Their page lists every one.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Raj Parekh

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Barrett

Director, Executive Officer · 2 shared filings (2 issuers) · also on 10 other issuers

Peter Barrett is on 12 issuers in total — a repeat sponsor. Their page lists every one.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Kristina Burow

Director · 2 shared filings (2 issuers) · also on 30 other issuers

Kristina Burow is on 32 issuers in total — a repeat sponsor. Their page lists every one.

NM
No photo found yet (own website and image search run after this page is viewed)
Person

Nagesh Mahanthappa

Executive Officer, Director · 2 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Michael Gilman. Their page shows their other deals.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Colleen Cuffaro

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy Springer

Director · 2 shared filings (2 issuers) · also on 5 other issuers

Timothy Springer is on 7 issuers in total — a repeat sponsor. Their page lists every one.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carolyn Green

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Gilman. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Katrine Bosley

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

FS
No photo found yet (own website and image search run after this page is viewed)
Person

F. RAYMOND SALEMME

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

ALAN BILOSKI

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

J. WESTON CASHMAN

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

IK
No photo found yet (own website and image search run after this page is viewed)
Person

IYA KHALIL

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

TN
No photo found yet (own website and image search run after this page is viewed)
Person

THOMAS NEYARAPALLY

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Gilman. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Duncan McFarland

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Gilman. Their page shows their other deals.

TP
No photo found yet (own website and image search run after this page is viewed)
Person

THOMAS PAUL

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

CH
No photo found yet (own website and image search run after this page is viewed)
Person

Colin Hill

Executive Officer, Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

EE
No photo found yet (own website and image search run after this page is viewed)
Person

Elan Z. Ezickson

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald Hunt

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Brad Maroni

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

SV
No photo found yet (own website and image search run after this page is viewed)
Person

Sheila Violette

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Kraus

Director · 1 shared filing (1 issuer) · also on 6 other issuers

Stephen Kraus is on 7 issuers in total — a repeat sponsor. Their page lists every one.

KH
No photo found yet (own website and image search run after this page is viewed)
Person

Karen Hong

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Alison Lawton

Executive Officer · 1 shared filing (1 issuer) · also on 4 other issuers

Alison Lawton is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John Cheney

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Arbeit

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

MW
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Wyzga

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jason Gardner

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Gilman. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Russell C. Petter

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Adam S. Mostafa

Executive Officer · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

CN
No photo found yet (own website and image search run after this page is viewed)
Person

Carolyn Ng

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Gilman. Their page shows their other deals.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Sudha Parasuraman

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John Celebi

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

NL
No photo found yet (own website and image search run after this page is viewed)
Person

Nancy Lurker

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Gilman. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Buckler

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Gilman. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

David Hallal

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Gilman. Their page shows their other deals.

The team behind the deals

SR
Sponsor group

Scholar Rock

2 issuers · 2 filings · $83.3M reported sold · 2016–2018

One team, 2 deal companies. Michael Gilman is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Michael Gilman.

XP
Sponsor group

X4 Pharmaceuticals

2 issuers · 16 filings · $120M reported sold · 2010–2025

One team, 2 deal companies. Michael Gilman is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Michael Gilman.

Same business address

13 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 7 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Michael Gilman by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 7 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Michael Gilman is listed on: none on file. No website or social profile named in Scholar Rock Holding Corp's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #260,682 of 374,652 in line (1,277 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Michael Gilman appears on a new Form D, or when a court case or SEC action is matched to them. See plans →